Rossby Financial
EW icon

Rossby Financial’s Edwards Lifesciences EW Stock Holding History

Rossby Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.4K Buy
480
+18
+4% +$1.6K 0.01% 985
2026
Q2 		$41.8K Buy
462
+23
+5% +$1.93K 0.01% 745
2026
Q1 		$35.7K Buy
439
+37
+9% +$3.05K 0.01% 845
2025
Q4 		$34.3K Buy
402
+10
+3% +$821 0.01% 617
2025
Q3 		$29.9K Buy
392
+4
+1% +$313 0.01% 633
2025
Q2 		$30.3K Buy
388
+12
+3% +$895 0.01% 580
2025
Q1 		$28.6K Buy
+376
New +$26.9K 0.01% 565

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return

Rossby Financial's EW Position: Q3 2026 in Review

Rossby Financial increased its Edwards Lifesciences (EW) stake by 3.9% in Q3 2026, buying an estimated $1.6K and bringing the position to 480 shares worth $41.4K. The position accounts for 0.01% of the portfolio, ranked #985.

Rossby Financial first reported a position in EW in Q1 2025 and has held it in 7 quarters since. The position peaked at $41.8K in Q2 2026. 851 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Rossby Financial held 480 shares of Edwards Lifesciences worth $41.4K as of Q3 2026.
  • Rossby Financial bought 18 Edwards Lifesciences shares in Q3 2026, an estimated $1.6K.
  • Edwards Lifesciences made up 0.01% of Rossby Financial's portfolio in Q3 2026, its #985 holding.
  • Rossby Financial first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 7 quarters since.
  • Rossby Financial's Edwards Lifesciences position peaked at $41.8K in Q2 2026.
  • 851 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.